Dendritic cell-derived exosomes from PDT-treated glioma cells enhance antitumor immunity as a subcellular vaccine - PubMed
4 hours ago
- #Exosome Therapy
- #Cancer Vaccine
- #Glioma Treatment
- Dendritic cell-derived exosomes from PDT-treated glioma cells can act as a subcellular vaccine to boost antitumor immunity.
- This study explores an innovative cancer vaccine approach combining photodynamic therapy (PDT) and exosomes from dendritic cells.
- The research highlights a potential new treatment avenue for gliomas by enhancing immune responses through exosome-based vaccination.
- All necessary ethical approvals were obtained for animal studies, with no declared competing interests among authors.